p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• Proliferating cell nuclear antigen (PCNA) is crucial for DNA replication and repair.
• Identifying PCNA-interacting proteins is key to understanding DNA metabolism and cell cycle regulation.

Purpose of the Study:

• To identify novel proteins associated with PCNA.
• To characterize the function and potential clinical relevance of a newly identified PCNA-associated factor, p15(PAF).

Main Methods:

• Yeast two-hybrid screening using PCNA as bait to identify interacting proteins.
• Subcellular localization studies (primarily nuclear).
• Analysis of conserved PCNA binding motifs and mutation studies to assess binding.
• Expression analysis of p15(PAF) in various tumor tissues.

Main Results:

• A novel 15 kDa protein, p15(PAF), was identified as a PCNA-associated factor.
• p15(PAF) shares a PCNA binding motif with other proteins like p21, and its overexpression competes with p21-PCNA binding.
• Mutation of the motif abrogated p15(PAF)'s PCNA binding.
• p15(PAF) expression was significantly elevated in multiple tumor types, particularly esophageal tumors.

Conclusions:

• p15(PAF) is a novel nuclear protein that binds to PCNA via a conserved motif.
• p15(PAF) interacts with PCNA and may modulate its function, potentially competing with other PCNA partners like p21.
• Elevated p15(PAF) expression in tumors suggests its potential as a prognostic marker for various human cancers.